{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:37:01Z","timestamp":1790660221905,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:00:00Z","timestamp":1520985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Lophius Biosciences GmbH"},{"name":"Qiagen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s11908-018-0610-4","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T07:41:24Z","timestamp":1521013284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Immune Monitoring for CMV in Transplantation"],"prefix":"10.1007","volume":"20","author":[{"given":"Michelle K.","family":"Yong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon R.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Manuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,14]]},"reference":[{"issue":"Suppl 4","key":"610_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/ajt.12103","volume":"13","author":"RR Razonable","year":"2013","unstructured":"Razonable RR, Humar A. Practice ASTIDCo. Cytomegalovirus in solid organ transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2013;13(Suppl 4):93\u2013106.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"5","key":"610_CR2","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","volume":"10","author":"A Humar","year":"2010","unstructured":"Humar A, Lebranchu Y, Vincenti F, Blumberg EA, Punch JD, Limaye AP, et al. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2010;10(5):1228\u201337.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"4","key":"610_CR3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","volume":"4","author":"C Paya","year":"2004","unstructured":"Paya C, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2004;4(4):611\u201320.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"3","key":"610_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/tid.12379","volume":"17","author":"KW Matter-Walstra","year":"2015","unstructured":"Matter-Walstra KW, Greiner M, Cusini A, Schiesser M, Ledergerber B, Fehr T, et al. Stringent adherence to a cytomegalovirus-prevention protocol is associated with reduced overall costs in the first 6 months after kidney transplantation. Transpl Infect Dis. 2015;17(3):342\u20139.","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"610_CR5","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1111\/ajt.12388","volume":"13","author":"O Manuel","year":"2013","unstructured":"Manuel O, Kralidis G, Mueller NJ, Hirsch HH, Garzoni C, van Delden C, et al. Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2013;13(9):2402\u201310.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"key":"610_CR6","doi-asserted-by":"publisher","unstructured":"Navarro D, San-Juan R, Manuel O, Gimenez E, Fernandez-Ruiz M, Hirsch HH, et al. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: an ESGICH survey. Transpl Infect Dis. 2017;19:e12773. https:\/\/doi.org\/10.1111\/tid.12773 .","DOI":"10.1111\/tid.12773"},{"issue":"19","key":"610_CR7","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa060068","volume":"355","author":"DC Brennan","year":"2006","unstructured":"Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D, Thymoglobulin Induction Study G. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med. 2006;355(19):1967\u201377.","journal-title":"N Engl J Med"},{"issue":"25","key":"610_CR8","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1056\/NEJMoa067411","volume":"357","author":"H Ekberg","year":"2007","unstructured":"Ekberg H, Tedesco-Silva H, Demirbas A, Vitko S, Nashan B, Gurkan A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med. 2007;357(25):2562\u201375.","journal-title":"N Engl J Med"},{"issue":"23","key":"610_CR9","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1182\/blood-2008-10-143560","volume":"113","author":"M Boeckh","year":"2009","unstructured":"Boeckh M, Ljungman P. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood. 2009;113(23):5711\u20139.","journal-title":"Blood"},{"issue":"4","key":"610_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","volume":"96","author":"CN Kotton","year":"2013","unstructured":"Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2013;96(4):333\u201360.","journal-title":"Transplantation"},{"issue":"5","key":"610_CR11","first-page":"500","volume":"69","author":"C Martin-Gandul","year":"2014","unstructured":"Martin-Gandul C, Perez-Romero P, Gonzalez-Roncero FM, Berdaguer S, Gomez MA, Lage E, et al. Clinical impact of neutropenia related with the preemptive therapy of CMV infection in solid organ transplant recipients. J Inf Secur. 2014;69(5):500\u20136.","journal-title":"J Inf Secur"},{"key":"610_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11908-013-0369-6","volume":"15","author":"O Manuel","year":"2013","unstructured":"Manuel O. Clinical experience with immune monitoring for cytomegalovirus in solid-organ transplant recipients. Curr Infect Dis Rep. 2013;15:491\u20136.","journal-title":"Curr Infect Dis Rep"},{"issue":"12","key":"610_CR13","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/lt.24355","volume":"21","author":"CN Kotton","year":"2015","unstructured":"Kotton CN. Cytomegalovirus immunodiagnostics: getting closer to personalized cytomegalovirus prevention? Liver Transpl. 2015;21(12):1462\u20134.","journal-title":"Liver Transpl"},{"issue":"6","key":"610_CR14","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1111\/ajt.13684","volume":"16","author":"M Sester","year":"2016","unstructured":"Sester M, Leboeuf C, Schmidt T, Hirsch HH. The \u201cABC\u201d of virus-specific T cell immunity in solid organ transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2016;16(6):1697\u2013706.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"11","key":"610_CR15","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/infdis\/jix192","volume":"215","author":"MK Yong","year":"2017","unstructured":"Yong MK, Cameron PU, Slavin M, Morrissey CO, Bergin K, Spencer A, et al. Identifying cytomegalovirus complications using the Quantiferon-CMV assay after allogeneic hematopoietic stem cell transplantation. J Infect Dis. 2017;215(11):1684\u201394.","journal-title":"J Infect Dis"},{"issue":"6","key":"610_CR16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/cid\/cis993","volume":"56","author":"O Manuel","year":"2013","unstructured":"Manuel O, Husain S, Kumar D, Zayas C, Mawhorter S, Levi ME, et al. Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013;56(6):817\u201324.","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"1","key":"610_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1586\/erm.10.109","volume":"11","author":"S Giulieri","year":"2011","unstructured":"Giulieri S, Manuel O. QuantiFERON(R)-CMV assay for the assessment of cytomegalovirus cell-mediated immunity. Expert Rev Mol Diagn. 2011;11(1):17\u201325.","journal-title":"Expert Rev Mol Diagn"},{"issue":"2","key":"610_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1399-3062.2006.00199.x","volume":"9","author":"S Walker","year":"2007","unstructured":"Walker S, Fazou C, Crough T, Holdsworth R, Kiely P, Veale M, et al. Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV. Transpl Infect Dis. 2007;9(2):165\u201370.","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"610_CR19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/sj.bmt.1705825","volume":"40","author":"G Avetisyan","year":"2007","unstructured":"Avetisyan G, Aschan J, Hagglund H, Ringden O, Ljungman P. Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT. Bone Marrow Transplant. 2007;40(9):865\u20139.","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"610_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074744","volume":"8","author":"SK Tey","year":"2013","unstructured":"Tey SK, Kennedy GA, Cromer D, Davenport MP, Walker S, Jones LI, et al. Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV(R) assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications. PLoS One. 2013;8(10):e74744.","journal-title":"PLoS One"},{"key":"610_CR21","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3389\/fimmu.2017.01506","volume":"8","author":"MK Yong","year":"2017","unstructured":"Yong MK, Cameron PU, Slavin MA, Cheng AC, Morrissey CO, Bergin K, et al. Low T-cell responses to mitogen stimulation predicts poor survival in recipients of allogeneic hematopoietic stem cell transplantation. Front Immunol. 2017;8:1506.","journal-title":"Front Immunol"},{"issue":"8","key":"610_CR22","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1128\/JCM.00563-13","volume":"51","author":"D Abate","year":"2013","unstructured":"Abate D, Saldan A, Mengoli C, Fiscon M, Silvestre C, Fallico L, et al. Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients. J Clin Microbiol. 2013;51(8):2501\u20137.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"610_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12865-017-0194-z","volume":"18","author":"B Banas","year":"2017","unstructured":"Banas B, Boger CA, Luckhoff G, Kruger B, Barabas S, Batzilla J, et al. Validation of T-track(R) CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients. BMC Immunol. 2017;18(1):15.","journal-title":"BMC Immunol"},{"issue":"1","key":"610_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12865-017-0195-y","volume":"18","author":"S Barabas","year":"2017","unstructured":"Barabas S, Spindler T, Kiener R, Tonar C, Lugner T, Batzilla J, et al. An optimized IFN-gamma ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity. BMC Immunol. 2017;18(1):14.","journal-title":"BMC Immunol"},{"issue":"11","key":"610_CR25","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1093\/infdis\/jiw064","volume":"213","author":"L Nesher","year":"2016","unstructured":"Nesher L, Shah DP, Ariza-Heredia EJ, Azzi JM, Siddiqui HK, Ghantoji SS, et al. Utility of the enzyme-linked Immunospot interferon-gamma-release assay to predict the risk of cytomegalovirus infection in hematopoietic cell transplant recipients. J Infect Dis. 2016;213(11):1701\u20137.","journal-title":"J Infect Dis"},{"key":"610_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jim.2014.05.021","volume":"409","author":"JS Staats","year":"2014","unstructured":"Staats JS, Enzor JH, Sanchez AM, Rountree W, Chan C, Jaimes M, et al. Toward development of a comprehensive external quality assurance program for polyfunctional intracellular cytokine staining assays. J Immunol Methods. 2014;409:44\u201353.","journal-title":"J Immunol Methods"},{"issue":"3","key":"610_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2013.11.007","volume":"78","author":"S Borchers","year":"2014","unstructured":"Borchers S, Ogonek J, Varanasi PR, Tischer S, Bremm M, Eiz-Vesper B, et al. Multimer monitoring of CMV-specific T cells in research and in clinical applications. Diagn Microbiol Infect Dis. 2014;78(3):201\u201312.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"610_CR28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1399-3062.2011.00626.x","volume":"13","author":"S Borchers","year":"2011","unstructured":"Borchers S, Luther S, Lips U, Hahn N, Kontsendorn J, Stadler M, et al. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2011;13(3):222\u201336.","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"610_CR29","doi-asserted-by":"publisher","first-page":"792","DOI":"10.4049\/jimmunol.1601992","volume":"199","author":"J Ogonek","year":"2017","unstructured":"Ogonek J, Verma K, Schultze-Florey C, Varanasi P, Luther S, Schweier P, et al. Characterization of high-avidity cytomegalovirus-specific T cells with differential tetramer binding Coappearing after allogeneic stem cell transplantation. J Immunol. 2017;199(2):792\u2013805.","journal-title":"J Immunol"},{"issue":"3","key":"610_CR30","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/ajt.12049","volume":"13","author":"S Cantisan","year":"2013","unstructured":"Cantisan S, Lara R, Montejo M, Redel J, Rodriguez-Benot A, Gutierrez-Aroca J, et al. Pretransplant interferon-gamma secretion by CMV-specific CD8+ T cells informs the risk of CMV replication after transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2013;13(3):738\u201345.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"7","key":"610_CR31","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1111\/ajt.12256","volume":"13","author":"O Bestard","year":"2013","unstructured":"Bestard O, Lucia M, Crespo E, Van Liempt B, Palacio D, Melilli E, et al. Pretransplant immediately early-1-specific T cell responses provide protection for CMV infection after kidney transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2013;13(7):1793\u2013805.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"11","key":"610_CR32","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/cid\/ciu589","volume":"59","author":"M Lucia","year":"2014","unstructured":"Lucia M, Crespo E, Melilli E, Cruzado JM, Luque S, Llaudo I, et al. Preformed frequencies of cytomegalovirus (CMV)-specific memory T and B cells identify protected CMV-sensitized individuals among seronegative kidney transplant recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014;59(11):1537\u201345.","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America."},{"issue":"10","key":"610_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001825","volume":"101","author":"T Schachtner","year":"2017","unstructured":"Schachtner T, Stein M, Reinke P. CMV-specific T cell monitoring offers superior risk stratification of CMV-seronegative kidney transplant recipients of a CMV-seropositive donor. Transplantation. 2017;101(10):e315-e25.","journal-title":"Transplantation"},{"issue":"5","key":"610_CR34","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/tid.12417","volume":"17","author":"R San-Juan","year":"2015","unstructured":"San-Juan R, Navarro D, Garcia-Reyne A, Montejo M, Munoz P, Carratala J, et al. Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+\/R- solid organ transplant recipients. Transpl Infect Dis. 2015;17(5):637\u201346.","journal-title":"Transpl Infect Dis"},{"key":"610_CR35","doi-asserted-by":"crossref","unstructured":"Westall GP, Cristiano Y, Peleg AY, Paraskeva M, Levvey B, Whitford H, et al. A study of QuantiFERON-CMV-directed CMV prophylaxis versus standard-of-care to reduce late CMV reactivation in patients undergoing lung transplantation. 37th International Society for Heart and Lung Transplantation Annual Meeting; San Diego, California 2017.","DOI":"10.1016\/j.healun.2017.01.527"},{"issue":"5","key":"610_CR36","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/j.1600-6143.2009.02617.x","volume":"9","author":"A Asberg","year":"2009","unstructured":"Asberg A, Humar A, Jardine AG, Rollag H, Pescovitz MD, Mouas H, et al. Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2009;9(5):1205\u201313.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"2","key":"610_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/00007890-200207270-00014","volume":"74","author":"C Muheim","year":"2002","unstructured":"Muheim C, Vogel G, Seydoux C, Gillet M, Mosimann F, Von Segesser L, et al. Determinants of protracted cytomegalovirus infection in solid-organ transplant patients. Transplantation. 2002;74(2):226\u201336.","journal-title":"Transplantation"},{"key":"610_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fimmu.2015.00003","volume":"6","author":"L Couzi","year":"2015","unstructured":"Couzi L, Pitard V, Moreau JF, Merville P, Dechanet-Merville J. Direct and indirect effects of cytomegalovirus-induced gammadelta T cells after kidney transplantation. Front Immunol. 2015;6:3.","journal-title":"Front Immunol"},{"issue":"2","key":"610_CR39","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1681\/ASN.2014100985","volume":"27","author":"H Kaminski","year":"2016","unstructured":"Kaminski H, Garrigue I, Couzi L, Taton B, Bachelet T, Moreau JF, et al. Surveillance of gammadelta T cells predicts cytomegalovirus infection resolution in kidney transplants. J Am Soc Nephrol. 2016;27(2):637\u201345.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"610_CR40","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1111\/ajt.14347","volume":"17","author":"D Kumar","year":"2017","unstructured":"Kumar D, Mian M, Singer L, An Interventional HA. Study using cell-mediated immunity to personalize therapy for cytomegalovirus infection after transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2017;17(9):2468\u201373.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"key":"610_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jcv.2016.06.013","volume":"82","author":"J Mihm","year":"2016","unstructured":"Mihm J, Leyking S, Dirks J, Smola S, Fliser D, Sester U, et al. Immune-based guidance of foscarnet treatment duration in a transplant recipient with ganciclovir-resistant cytomegalovirus infection. J Clin Virol. 2016;82:5\u20138.","journal-title":"J Clin Virol"},{"issue":"2","key":"610_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/TP.0b013e31823c1cd4","volume":"93","author":"LF Lisboa","year":"2012","unstructured":"Lisboa LF, Kumar D, Wilson LE, Humar A. Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremia. Transplantation. 2012;93(2):195\u2013200.","journal-title":"Transplantation"},{"issue":"4","key":"610_CR43","first-page":"336","volume":"75","author":"JD Mena-Romo","year":"2017","unstructured":"Mena-Romo JD, Perez Romero P, Martin-Gandul C, Gentil MA, Suarez-Artacho G, Lage E, et al. CMV-specific T-cell immunity in solid organ transplant recipients at low risk of CMV infection. Chronology and applicability in preemptive therapy. J Inf Secur. 2017;75(4):336\u201345.","journal-title":"J Inf Secur"},{"issue":"2","key":"610_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/sj.bmt.1704543","volume":"34","author":"K Thursky","year":"2004","unstructured":"Thursky K, Byrnes G, Grigg A, Szer J, Slavin M. Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation. Bone Marrow Transplant. 2004;34(2):115\u201321.","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"610_CR45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.7326\/0003-4819-118-3-199302010-00003","volume":"118","author":"JM Goodrich","year":"1993","unstructured":"Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalovirus diseases after allogeneic marrow transplant. Ann Intern Med. 1993;118(3):173\u20138.","journal-title":"Ann Intern Med"},{"issue":"2","key":"610_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1399-3062.2011.00706.x","volume":"14","author":"B George","year":"2012","unstructured":"George B, Kerridge IH, Gilroy N, Huang G, Hertzberg MS, Bradstock KF, et al. A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group. Transpl Infect Dis. 2012;14(2):141\u20138.","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"610_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw107","volume":"3","author":"D Navarro","year":"2016","unstructured":"Navarro D, Amat P, de la Camara R, Lopez J, Vazquez L, Serrano D, et al. Efficacy and safety of a preemptive antiviral therapy strategy based on combined virological and immunological monitoring for active cytomegalovirus infection in allogeneic stem cell transplant recipients. Open Forum Infect Dis. 2016;3(2):ofw107.","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"610_CR48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3343\/alm.2017.37.3.277","volume":"37","author":"SM Lee","year":"2017","unstructured":"Lee SM, Kim YJ, Yoo KH, Sung KW, Koo HH, Kang ES. Clinical usefulness of monitoring cytomegalovirus-specific immunity by Quantiferon-CMV in pediatric allogeneic hematopoietic stem cell transplantation recipients. Ann Lab Med. 2017;37(3):277\u201381.","journal-title":"Ann Lab Med"},{"issue":"12","key":"610_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050248","volume":"7","author":"S Borchers","year":"2012","unstructured":"Borchers S, Bremm M, Lehrnbecher T, Dammann E, Pabst B, Wolk B, et al. Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation. PLoS One. 2012;7(12):e50248.","journal-title":"PLoS One"},{"issue":"4","key":"610_CR50","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1097\/TP.0b013e318224f263","volume":"92","author":"C Solano","year":"2011","unstructured":"Solano C, Benet I, Remigia MJ, de la Camara R, Munoz-Cobo B, Costa E, et al. Immunological monitoring for guidance of preemptive antiviral therapy for active cytomegalovirus infection in allogeneic stem-cell transplant recipients: a pilot experience. Transplantation. 2011;92(4):e17\u201320.","journal-title":"Transplantation"},{"issue":"2","key":"610_CR51","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3109\/14653249.2011.634402","volume":"14","author":"M Hoegh-Petersen","year":"2012","unstructured":"Hoegh-Petersen M, Roa L, Liu Y, Zhou F, Ugarte-Torres A, Louie P, et al. Low cytomegalovirus-specific T-cell counts at reactivation are associated with progression to high-level viremia or disease in seropositive recipients of hematopoietic cell grafts from seropositive but not seronegative donors. Cytotherapy. 2012;14(2):194\u2013204.","journal-title":"Cytotherapy"},{"issue":"7","key":"610_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041648","volume":"7","author":"D Lilleri","year":"2012","unstructured":"Lilleri D, Gerna G, Zelini P, Chiesa A, Rognoni V, Mastronuzzi A, et al. Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation. PLoS One. 2012;7(7):e41648.","journal-title":"PLoS One"},{"issue":"8","key":"610_CR53","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/bmt.2010.261","volume":"46","author":"L Krol","year":"2011","unstructured":"Krol L, Stuchly J, Hubacek P, Keslova P, Sedlacek P, Stary J, et al. Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT. Bone Marrow Transplant. 2011;46(8):1089\u201398.","journal-title":"Bone Marrow Transplant"},{"key":"610_CR54","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","volume":"377","author":"FM Marty","year":"2017","unstructured":"Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, et al. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med. 2017;377:2433\u201344.","journal-title":"N Engl J Med"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-018-0610-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-018-0610-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-018-0610-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T20:45:14Z","timestamp":1570913114000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-018-0610-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,14]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["610"],"URL":"https:\/\/doi.org\/10.1007\/s11908-018-0610-4","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,14]]},"assertion":[{"value":"14 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Manuel has received research grants from Lophius Biosciences GmbH and from Qiagen. Dr. Yong and Dr. Lewin declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"4"}}